Showing results (81-90 of 3,654) with videos related to
Sort By:
Pageof 366
Breast Cancer Research : BCR|August 31, 2017
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.Breast Cancer Research : BCR|September 4, 2017
Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotypeHidetoshi Mori, Jane Q Chen, Robert D Cardiff, et al.Breast Cancer Research : BCR|August 3, 2017
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancerKomal Jhaveri, Rui Wang, Eleonora Teplinsky, et al.Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.Breast Cancer Research : BCR|February 22, 2016
Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent mannerJoshua Ogony, Hye Joung Choi, Asona Lui, et al.Breast Cancer Research : BCR|December 3, 2015
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortAdam R Brentnall, Elaine F Harkness, Susan M Astley, et al.Breast Cancer Research : BCR|February 19, 2016
LIN7A is a major determinant of cell-polarity defects in breast carcinomasNadège Gruel, Laetitia Fuhrmann, Catalina Lodillinsky, et al.Breast Cancer Research : BCR|July 29, 2022
Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomasSanghoon Lee, Hatice Ulku OsmanbeyogluBreast Cancer Research : BCR|June 22, 2018
Correction to: Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1Kheng Tian Lim, Niamh Cosgrave, Arnold David Hill, et al.Breast Cancer Research : BCR|March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeMiriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.Pageof 366